Victoria Ives-Deliperi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Victoria Ives-Deliperi has a total of 268 co-authors. Here are the top co-authors by number of shared publications:
- James Butler
Neuroscience Institute, University of Cape Town, Cape Town, South Africa
8 shared publications - Anna Elisabetta Vaudano
Unità di Neurofisiologia e Centro Epilessia, Azienda Ospedaliero‐Universitaria di Modena, Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze Università di Modena e Reggio‐Emilia Modena Italy
5 shared publications - Chrisma Pretorius
Department of Psychology Stellenbosch University Stellenbosch South Africa
5 shared publications - Daniel Joseph Stein
University of Cape Town
5 shared publications - Fernando Cendes
Department of Neurology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil
5 shared publications - Gabriele Vilyte
Department of Psychology, Faculty of Arts and Social Sciences, Stellenbosch University, Stellenbosch, South Africa
5 shared publications
Latest Publications
- Open Access
Limited sex‐specific structural alterations across common epilepsies: A worldwide ENIGMA study
Objective: Epilepsy is characterized by widespread cortical and subcortical structural alterations beyond the epileptic zone. Importantly, the clinical manifestation of epilepsy, including seizure types, psychiatric comorbidities, and treatment responses, has been shown to differ between sexes. However, sex differences in structural alterations in epilepsy are seldomly reported in neuroimaging studies, partly due to limited sample sizes and single‐center designs. We therefore tested whether epilepsy‐related structural alterations differ between males and females, and whether the associations between structural measures and clinical characteristics vary by sex. Methods: We analyzed clinician‐assigned biological sex differences in common epilepsies and their related clinical variables using structural neuroimaging biomarkers in an international multicenter cohort of 1253 epilepsy patients and 1077 healthy controls. We studied cortical thickness and subcortical volume in temporal lobe epilepsy (TLE) and genetic generalized epilepsy (GGE). Results: Both male and female patients with TLE showed widespread cortical and subcortical alterations in sex‐stratified analyses, whereas GGE showed more extensive alterations in female patients and only subtle alterations in male patients. However, no significant sex‐by‐diagnosis interactions were identified in either the TLE ( t = −2.153 to 1.705, all p FDR >.05) or GGE ( t = −1.797 to 2.774, all p FDR >.05) cohort. Likewise, no significant interactions were found between sex and age at onset ( t TLE = −1.835 to 1.092, t GGE = −2.394 to 1.392, all p FDR >.05) or disease duration ( t TLE = −2.643 to 2.048, t GGE = −1.234 to 2.017, all p FDR >.05) in either patient group. Significance: Overall, although sex differences in behavioral and clinical outcomes of epilepsy have been consistently reported in previous studies, our results indicate that sex‐related clinical differences in epilepsy are not strongly captured by macroscale structural magnetic resonance imaging measures, and may instead arise from hormonal, neurochemical, or functional–network mechanisms.
Open AccessLimited sex‐specific structural alterations across common epilepsies: A worldwide ENIGMA study
Objective: Epilepsy is characterized by widespread cortical and subcortical structural alterations beyond the epileptic zone. Importantly, the clinical manifestation of epilepsy, including seizure types, psychiatric comorbidities, and treatment responses, has been shown to differ between sexes. However, sex differences in structural alterations in epilepsy are seldomly reported in neuroimaging studies, partly due to limited sample sizes and single‐center designs. We therefore tested whether epilepsy‐related structural alterations differ between males and females, and whether the associations between structural measures and clinical characteristics vary by sex. Methods: We analyzed clinician‐assigned biological sex differences in common epilepsies and their related clinical variables using structural neuroimaging biomarkers in an international multicenter cohort of 1253 epilepsy patients and 1077 healthy controls. We studied cortical thickness and subcortical volume in temporal lobe epilepsy (TLE) and genetic generalized epilepsy (GGE). Results: Both male and female patients with TLE showed widespread cortical and subcortical alterations in sex‐stratified analyses, whereas GGE showed more extensive alterations in female patients and only subtle alterations in male patients. However, no significant sex‐by‐diagnosis interactions were identified in either the TLE ( t = −2.153 to 1.705, all p FDR >.05) or GGE ( t = −1.797 to 2.774, all p FDR >.05) cohort. Likewise, no significant interactions were found between sex and age at onset ( t TLE = −1.835 to 1.092, t GGE = −2.394 to 1.392, all p FDR >.05) or disease duration ( t TLE = −2.643 to 2.048, t GGE = −1.234 to 2.017, all p FDR >.05) in either patient group. Significance: Overall, although sex differences in behavioral and clinical outcomes of epilepsy have been consistently reported in previous studies, our results indicate that sex‐related clinical differences in epilepsy are not strongly captured by macroscale structural magnetic resonance imaging measures, and may instead arise from hormonal, neurochemical, or functional–network mechanisms.
- Open Access
- 25 March 2026
- Published by Wiley in Epilepsia Open
Abnormal functional connectivity patterns in temporal lobe epilepsy—An international ENIGMA ‐epilepsy study
Objectives: Temporal lobe epilepsy (TLE) impacts multiple brain networks. Aberrant functional connectivity has been demonstrated in resting‐state networks (RSNs) that mediate higher brain functions in TLE. This study aimed to identify the reproducible patterns of altered functional connectivity in TLE in a large, international cohort through ENIGMA‐Epilepsy. Methods: Resting‐state functional MRI datasets from nine centers across North America, South America, Europe and South Africa, including 442 people with TLE and 387 healthy adults, were analyzed. We examined group differences in whole‐brain connectivity in patients compared to controls in seven major RSNs. We also investigated whole‐brain connectivity maps for key nodes within the default mode network (DMN). Furthermore, the associations between connectivity patterns and clinical variables were assessed. Results: We found lower within‐network connectivity scores (13.6% on average) and higher between‐network connectivity scores (129% on average) in non‐limbic RSN in TLE. This pattern was reproducible across all seven sites and most robust for DMN and visual networks. Patterns of connectivity were not associated with age of seizure onset or disease duration and were mostly similar in patients with left and right TLE with a few exceptions; isolated regions of high connectivity in left TLE and lower connectivity in right TLE compared to controls. Significance: We show strong evidence of lower connectivity within most RSNs and higher connectivity outside of these networks that was highly consistent across geographically diverse sites, demonstrating the robustness and generalizability of our findings. The findings demonstrate a consistent disruption of network organization in TLE that may underlie cognitive co‐morbidities and seizure propagation patterns observed in this patient population. Plain Language Summary: In this international ENIGMA‐Epilepsy study, resting‐state fMRI data from 442 individuals with TLE showed reduced connectivity within major resting‐state networks (about 14% lower) and markedly increased connectivity between networks (about 129% higher), compared to 387 healthy controls. These patterns were highly reproducible across sites. Connectivity alterations were not related to age of onset or disease duration and were largely similar across left and right TLE, aside from small, region‐specific differences. Overall, the study demonstrates a robust, widespread reorganization of brain network connectivity in TLE, which may help explain associated cognitive difficulties and seizure spread.
- 25 March 2026
- Published by Wiley in Epilepsia Open
Open AccessAbnormal functional connectivity patterns in temporal lobe epilepsy—An international ENIGMA ‐epilepsy study
Objectives: Temporal lobe epilepsy (TLE) impacts multiple brain networks. Aberrant functional connectivity has been demonstrated in resting‐state networks (RSNs) that mediate higher brain functions in TLE. This study aimed to identify the reproducible patterns of altered functional connectivity in TLE in a large, international cohort through ENIGMA‐Epilepsy. Methods: Resting‐state functional MRI datasets from nine centers across North America, South America, Europe and South Africa, including 442 people with TLE and 387 healthy adults, were analyzed. We examined group differences in whole‐brain connectivity in patients compared to controls in seven major RSNs. We also investigated whole‐brain connectivity maps for key nodes within the default mode network (DMN). Furthermore, the associations between connectivity patterns and clinical variables were assessed. Results: We found lower within‐network connectivity scores (13.6% on average) and higher between‐network connectivity scores (129% on average) in non‐limbic RSN in TLE. This pattern was reproducible across all seven sites and most robust for DMN and visual networks. Patterns of connectivity were not associated with age of seizure onset or disease duration and were mostly similar in patients with left and right TLE with a few exceptions; isolated regions of high connectivity in left TLE and lower connectivity in right TLE compared to controls. Significance: We show strong evidence of lower connectivity within most RSNs and higher connectivity outside of these networks that was highly consistent across geographically diverse sites, demonstrating the robustness and generalizability of our findings. The findings demonstrate a consistent disruption of network organization in TLE that may underlie cognitive co‐morbidities and seizure propagation patterns observed in this patient population. Plain Language Summary: In this international ENIGMA‐Epilepsy study, resting‐state fMRI data from 442 individuals with TLE showed reduced connectivity within major resting‐state networks (about 14% lower) and markedly increased connectivity between networks (about 129% higher), compared to 387 healthy controls. These patterns were highly reproducible across sites. Connectivity alterations were not related to age of onset or disease duration and were largely similar across left and right TLE, aside from small, region‐specific differences. Overall, the study demonstrates a robust, widespread reorganization of brain network connectivity in TLE, which may help explain associated cognitive difficulties and seizure spread.
- Open Access
- 13 March 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 179, 111001
Cognitive phenotypes in adults with temporal lobe epilepsy from South Africa – A contribution to the international classification of cognitive disorders in epilepsy (IC-CoDE)
- 13 March 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 179, 111001
Open AccessCognitive phenotypes in adults with temporal lobe epilepsy from South Africa – A contribution to the international classification of cognitive disorders in epilepsy (IC-CoDE)
- 24 February 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (4) , e214613
Timing for Starting Antiseizure Medication Withdrawal After Epilepsy Surgery in Adults
More than half of people undergoing epilepsy surgery become seizure-free and may consider withdrawing antiseizure medications (ASMs). Withdrawal practices vary, and the optimal timing remains unclear. We aim to compare seizure relapse risk among individuals initiating ASM withdrawal at different time points after epilepsy surgery. We conducted a multicenter observational cohort study of adults who underwent resective epilepsy surgery between 1990 and 2016 at 12 tertiary centers. Participants were seizure-free before medication withdrawal and had at least 1 year of follow-up. Seizure relapse risk was compared among those initiating withdrawal 1, 2, 3, 4, or 5 years postoperatively vs later. We used propensity score matching for each comparison to adjust for treatment selection bias. Of the 964 people included (51% female; median age at surgery 34 years [interquartile range 26-44]), 446 (46%) began ASM withdrawal in the first year after surgery, 255 (26%) in the second, 110 (11%) in the third, 58 (6%) in the fourth, 29 (3%) in the fifth, and 66 (7%) after the fifth year. After matching, those starting withdrawal in the first (hazard ratio [HR] 1.4; p = 0.003) or second (HR 1.18; p < 0.001) year had a higher risk of relapse than those who withdrew later. Starting withdrawal in the third (HR 1.7; p = 0.12), fourth (HR 1.3; p = 0.45), or fifth (HR 0.17; p = 0.82) year after surgery showed no increase in risk compared with later withdrawal. Long-term outcomes, such as seizure freedom and being entirely off ASMs at the final follow-up, were not substantially associated with withdrawal timing. Initiating ASM withdrawal within the first 2 postoperative years was linked to a higher initial risk of seizure relapse compared with later withdrawal, although long-term outcomes were similar regardless of withdrawal timing. Waiting more than 2 years did not confer additional benefit in reducing seizure risk. Deciding whether and when to withdraw ASMs is a shared process involving individuals, caregivers, and clinicians, balancing preferences, risk of injury, social factors (e.g., driving, work, and supervision), and clinical judgment. Transparent information on risks and benefits is essential. Our findings offer real-world evidence that may inform future evidence-based withdrawal protocols and follow-up strategies.
- 24 February 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (4) , e214613
Timing for Starting Antiseizure Medication Withdrawal After Epilepsy Surgery in Adults
More than half of people undergoing epilepsy surgery become seizure-free and may consider withdrawing antiseizure medications (ASMs). Withdrawal practices vary, and the optimal timing remains unclear. We aim to compare seizure relapse risk among individuals initiating ASM withdrawal at different time points after epilepsy surgery. We conducted a multicenter observational cohort study of adults who underwent resective epilepsy surgery between 1990 and 2016 at 12 tertiary centers. Participants were seizure-free before medication withdrawal and had at least 1 year of follow-up. Seizure relapse risk was compared among those initiating withdrawal 1, 2, 3, 4, or 5 years postoperatively vs later. We used propensity score matching for each comparison to adjust for treatment selection bias. Of the 964 people included (51% female; median age at surgery 34 years [interquartile range 26-44]), 446 (46%) began ASM withdrawal in the first year after surgery, 255 (26%) in the second, 110 (11%) in the third, 58 (6%) in the fourth, 29 (3%) in the fifth, and 66 (7%) after the fifth year. After matching, those starting withdrawal in the first (hazard ratio [HR] 1.4; p = 0.003) or second (HR 1.18; p < 0.001) year had a higher risk of relapse than those who withdrew later. Starting withdrawal in the third (HR 1.7; p = 0.12), fourth (HR 1.3; p = 0.45), or fifth (HR 0.17; p = 0.82) year after surgery showed no increase in risk compared with later withdrawal. Long-term outcomes, such as seizure freedom and being entirely off ASMs at the final follow-up, were not substantially associated with withdrawal timing. Initiating ASM withdrawal within the first 2 postoperative years was linked to a higher initial risk of seizure relapse compared with later withdrawal, although long-term outcomes were similar regardless of withdrawal timing. Waiting more than 2 years did not confer additional benefit in reducing seizure risk. Deciding whether and when to withdraw ASMs is a shared process involving individuals, caregivers, and clinicians, balancing preferences, risk of injury, social factors (e.g., driving, work, and supervision), and clinical judgment. Transparent information on risks and benefits is essential. Our findings offer real-world evidence that may inform future evidence-based withdrawal protocols and follow-up strategies.
- Open Access
- 14 December 2025
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 134, 204-210
Sex differences in the clinical characteristics of South African patients with functional seizures in a public and a private hospital
- 14 December 2025
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 134, 204-210
Open AccessSex differences in the clinical characteristics of South African patients with functional seizures in a public and a private hospital
- Open Access
- 10 December 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 175, 110843
Diagnostic delay and associated clinical factors in a sample of South African patients with functional seizures
- 10 December 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 175, 110843
Open AccessDiagnostic delay and associated clinical factors in a sample of South African patients with functional seizures
- Open Access
- 13 June 2025
- Published by Wiley in Epileptic Disorders
- Vol. 27 (5) , 729-744
Diagnostic Challenges in the Neuropsychology of Epilepsy: Report of the ILAE Neuropsychology Task Force Diagnostic Methods Commission: 2021–2025
Increasingly, it has been recognized that non‐seizure‐related factors influence how people with epilepsy perform on neuropsychological tests. Therefore, neuropsychologists need to recognize the constellation of factors that can contribute to the neurocognitive presentation of a person with epilepsy and consider these factors in the interpretation of their assessment results. In this paper, we highlight common scenarios prompting the need to account for such factors when conducting and interpreting neuropsychological assessments. To illustrate these complexities, a case study is presented of a woman with early onset epilepsy complicated by a traumatic brain injury in adulthood who was a candidate for epilepsy surgery. A discussion of the need to consider neurodevelopmental, psychiatric, and psychosocial factors in conducting an assessment and arriving at a sound interpretation of results is presented. Clinical take‐away points are offered for guidance in undertaking such assessments.
- 13 June 2025
- Published by Wiley in Epileptic Disorders
- Vol. 27 (5) , 729-744
Open AccessDiagnostic Challenges in the Neuropsychology of Epilepsy: Report of the ILAE Neuropsychology Task Force Diagnostic Methods Commission: 2021–2025
Increasingly, it has been recognized that non‐seizure‐related factors influence how people with epilepsy perform on neuropsychological tests. Therefore, neuropsychologists need to recognize the constellation of factors that can contribute to the neurocognitive presentation of a person with epilepsy and consider these factors in the interpretation of their assessment results. In this paper, we highlight common scenarios prompting the need to account for such factors when conducting and interpreting neuropsychological assessments. To illustrate these complexities, a case study is presented of a woman with early onset epilepsy complicated by a traumatic brain injury in adulthood who was a candidate for epilepsy surgery. A discussion of the need to consider neurodevelopmental, psychiatric, and psychosocial factors in conducting an assessment and arriving at a sound interpretation of results is presented. Clinical take‐away points are offered for guidance in undertaking such assessments.
- 16 April 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 168, 110430
Long-term seizure and quality of life outcomes of an epilepsy surgery program in Cape Town, South Africa
- 16 April 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 168, 110430
Long-term seizure and quality of life outcomes of an epilepsy surgery program in Cape Town, South Africa
- Open Access
- 17 December 2024
- Published by Taylor & Francis in The World Journal of Biological Psychiatry
- Vol. 26 (1) , 37-48
Systematic review of genome-wide association studies (GWAS) of epilepsy identifies common risk variants and associated genes
The aetiology of epilepsy is known to have genetic contributions, yet results from genome-wide association studies (GWAS) have not always been consistent. We undertook a systematic review in order to identify risk variants for epilepsy. This systematic review was conducted in accordance with the PRISMA protocol. The quality of each of the studies was evaluated using the Q-Genie tool. A total of 79 SNPs, located in 64 genes, were significantly associated with epilepsy at the genome-wide level. The majority of the variants were intronic and intergenic, with SCN1A as the most widely reported gene involved across studies. Two SNPs, rs2292096 and rs149212747, linked respectively to focal epilepsy (FE) and status epilepticus, were exclusively identified in individuals of Asian ancestry, alongside an Asian-exclusive synonymous variant (rs3782886) in BRAP and a missense variant (rs671) in ALDH2. Genes, which encode for ion and transport channels, transcription factors, ubiquitin ligase and transporter proteins were identified as potentially involved in the aetiology of epilepsy. The review identified one missense and one synonymous variant which deserve further exploration. Future research should include populations of more diverse ancestries, which may reveal unique epilepsy-associated genes.
- 17 December 2024
- Published by Taylor & Francis in The World Journal of Biological Psychiatry
- Vol. 26 (1) , 37-48
Open AccessSystematic review of genome-wide association studies (GWAS) of epilepsy identifies common risk variants and associated genes
The aetiology of epilepsy is known to have genetic contributions, yet results from genome-wide association studies (GWAS) have not always been consistent. We undertook a systematic review in order to identify risk variants for epilepsy. This systematic review was conducted in accordance with the PRISMA protocol. The quality of each of the studies was evaluated using the Q-Genie tool. A total of 79 SNPs, located in 64 genes, were significantly associated with epilepsy at the genome-wide level. The majority of the variants were intronic and intergenic, with SCN1A as the most widely reported gene involved across studies. Two SNPs, rs2292096 and rs149212747, linked respectively to focal epilepsy (FE) and status epilepticus, were exclusively identified in individuals of Asian ancestry, alongside an Asian-exclusive synonymous variant (rs3782886) in BRAP and a missense variant (rs671) in ALDH2. Genes, which encode for ion and transport channels, transcription factors, ubiquitin ligase and transporter proteins were identified as potentially involved in the aetiology of epilepsy. The review identified one missense and one synonymous variant which deserve further exploration. Future research should include populations of more diverse ancestries, which may reveal unique epilepsy-associated genes.
- Open Access
- 27 September 2024
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 122, 71-79
Functional seizure semiology and classification in a public and private hospital
- 27 September 2024
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 122, 71-79
Open AccessFunctional seizure semiology and classification in a public and private hospital